Biology Products
Mouse Anti-Snail, a.a. 150-39 Antibody, Unconjugated from CHEMICON
Description:Snail, a.a. 150-39...Company:CHEMICON
Rat Anti-Mouse IgM Heavy Chain Monoclonal Antibody, Unconjugated, Clone LO-MM-3 from Cell Sciences
Description:Anti-Mouse IgM Heavy Chain, Clone LO-MM-3, Monoclonal Antibody...Company:Cell Sciences
Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:HOXC11 Antibody...Company:ProSci, Inc
Rabbit Anti-BAFF-R (CT) BR3 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:BAFF-R (CT) BR3 Affinity Purified Polyclonal Antibody...Company:ProSci, Inc
Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:HOXC11 Antibody...Company:ProSci, Inc
Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:HOXC11 Antibody...Company:ProSci, Inc
Goat Anti-NIR1 Polyclonal Antibody, Unconjugated from Abcam
Description:Goat polyclonal to NIR1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: SWARGPPKFESVP, corresponding to C terminal amino acids 962-974 of NIR1. Entrez Gene ID: 83394 Swiss Protein ID: Q9BZ71...Company:Abcam
Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:HOXC11 Antibody...Company:ProSci, Inc
Rabbit Anti-NeuroD 6 Antibody, Unconjugated from CHEMICON
Description:Anti-NeuroD 6 Immunogen: Synthetic peptide. Available Date: 36708...Company:CHEMICON
Mouse Anti-Human PMM2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Description:PMM2 Immunogen: PMM2 (NP_000294, 47 a.a. ~ 112 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...Company:ABR-Affinity BioReagents
(Date:12/9/2013)... FRANCISCO, CA Since World War II, US nautical ... the Pacific Coast between San Francisco and the Mexican ... the amount, location, or nature of the materials that ... week,s meeting of the American Geophysical Union in San ... (MBARI) describe a survey of one supposed deep‐water dump ...
(Date:12/9/2013)... together for the first UK multidisciplinary, integrated, ... 2014 in Manchester, UK. , This conference ... research and help to build collaborations across ... social scientists and national facilities. , Duncan ... the RCUK Cross Council Bioenergy Strategic Coordination ...
(Date:12/9/2013)... international team of scientists supported by the Helmholtz ... interaction functions and how lymphotoxin controls the production ... published in the latest issue of the specialist ... (also known as gut flora) and an immune ... balance in the gastrointestinal tract. One important agent ...
Breaking Biology News(10 mins):Survey of supposed deep-sea chemical munitions dump off Southern California 2Survey of supposed deep-sea chemical munitions dump off Southern California 3New insights into the immune system of the gastrointestinal tract 2... more successfully in the future. Towards this aim, researchers ... Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have been ... a three-dimensional virtual "Kidney Atlas". It incorporates the latest ... kidney. The Kidney Atlas was part of the European ...
... Iowa -- Stress may indeed be a direct contributor ... State University study finding that increased levels of stress ... them being overweight or obese. The study of ... income families living in three cities -- Boston, Chicago ...
... UK, 14 May 2009 - A new article published in ... that our feelings in our lifetime can affect our children. ... chemicals that our brain generates when we are in different ... that ultimately produce the next generation. Such natural chemicals could ...
Cached Biology News:3-D kidney atlas created for researchers and physicians 2Study finds link between individual stress and adolescent obesity 2Study finds link between individual stress and adolescent obesity 3...
Pronase Reagent...
CircuLex Anti-Human S100P Polyclonal Antibody Research Focus: proliferation Storage: -20C Shipping Temperature: 4C...
Rabbit polyclonal to ECSIT ( Abpromise for all tested applications). entrezGeneID: 51295 SwissProtID: Q96HQ7...
Biology Products:(Date:12/9/2013)... When representatives of the Organization for the ... to receive the 2013 Nobel Peace Prize, they will ... from 21 scientific laboratories around the world, including two ... (LLNL) is one of the two U.S. laboratories; it ... U.S. Army's Edgewood Chemical Biological Center, located at the ...
(Date:12/9/2013)... electricity is not difficult, but doing so efficiently and ... why people still rely on the electric grid and ... team of researchers from the University of Illinois at ... may be one step closer to tapping into the ... way to create large sheets of nanotextured, silicon micro-cell ...
(Date:12/9/2013)... 2013 NKT Therapeutics (NKTT) today presented research results ... (NKT14) or activate (NKT14m) murine iNKT cells. The results ... complete and long lasting depletion of both peripheral blood ... NKT14m can produce iNKT cell activation in peripheral and ... in a poster session at the 55 th ...
(Date:12/9/2013)... , Dec. 9, 2013 Sangamo ... the presentation of preclinical data from its ZFP ... of both sickle cell disease (SCD) and beta-thalassemia. ... proprietary and highly specific zinc finger nuclease (ZFN) ... of fetal gamma-globin in adult red blood cells ...
Breaking Biology Technology:Livermore Scientists Part of Organization That Will Receive Nobel Peace Prize Tuesday 2Livermore Scientists Part of Organization That Will Receive Nobel Peace Prize Tuesday 3NKT Therapeutics' Identifies Novel anti-iNKT Antibodies for Depleting or Activating iNKT Cells 2Sangamo BioSciences Announces First Presentation Of Data From ZFP Therapeutic Program For Treatment Of Sickle Cell Disease And Beta-Thalassemia At American Society Of Hematology Meeting 2Sangamo BioSciences Announces First Presentation Of Data From ZFP Therapeutic Program For Treatment Of Sickle Cell Disease And Beta-Thalassemia At American Society Of Hematology Meeting 3Sangamo BioSciences Announces First Presentation Of Data From ZFP Therapeutic Program For Treatment Of Sickle Cell Disease And Beta-Thalassemia At American Society Of Hematology Meeting 4Sangamo BioSciences Announces First Presentation Of Data From ZFP Therapeutic Program For Treatment Of Sickle Cell Disease And Beta-Thalassemia At American Society Of Hematology Meeting 5Sangamo BioSciences Announces First Presentation Of Data From ZFP Therapeutic Program For Treatment Of Sickle Cell Disease And Beta-Thalassemia At American Society Of Hematology Meeting 6Sangamo BioSciences Announces First Presentation Of Data From ZFP Therapeutic Program For Treatment Of Sickle Cell Disease And Beta-Thalassemia At American Society Of Hematology Meeting 7[0] Livermore Scientists Part of Organization That Will Receive Nobel Peace Prize Tuesday[0] Research team finds way to make solar cells thin, efficient and flexible[0] NKT Therapeutics' Identifies Novel anti-iNKT Antibodies for Depleting or Activating iNKT Cells[0] Sangamo BioSciences Announces First Presentation Of Data From ZFP Therapeutic Program For Treatment Of Sickle Cell Disease And Beta-Thalassemia At American Society Of Hematology Meeting
... 1 PAREXEL International Corporation (Nasdaq: PRXL ) announced ... Conference in New York, NY. James F. Winschel, Jr., Senior ... presentation on PAREXEL at 10:30 a.m. EDT on Wednesday, September 9, ... presentation will be available under the "Upcoming Events" section on PAREXEL,s ...
... , , PLEASANTON, Calif., Sept. ... leader in device-based mechanical circulatory support therapies to save, support and ... the Robert W. Baird & Co. Healthcare Conference on Wednesday, September ... president and chief financial officer, will provide an update on the ...
... , , ROCKVILLE, Md., ... today favorable results from a Phase II human clinical trial of ... vaccine was well tolerated and induced robust immune responses against all ... support the planned study in elderly adults scheduled for the fourth ...
Cached Biology Technology:PAREXEL International to Present at Robert Baird 2009 Healthcare Conference 2NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate 2NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate 3NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate 4NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate 5| Copyright © 2003-2007 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |